术前足部感染与慢性肢体威胁性缺血远端旁路术后静脉移植物狭窄的性别特异性关联
单中心回顾性研究纳入318例慢性肢体威胁性缺血行踝周或踝下自体静脉旁路术的肢体,分析显示女性术后5年静脉移植物狭窄累积发生率高于男性(44% vs 9%),且术前高级别足部感染与女性狭窄相关(HR 4.27),与男性无关,提示女性对感染相关炎症的静脉壁反应存在性别差异。
要点
- 女性单静脉远端旁路术后5年静脉移植物狭窄发生率显著高于男性。
- 术前高级别足部感染仅与女性静脉移植物狭窄相关,存在显著性别交互作用。
- 女性静脉移植物狭窄独立相关因素包括足部感染、静脉质量差和流出道阻力。
核心结论
- 女性行单静脉远端旁路术后静脉移植物狭窄发生率更高,且超额风险集中于术前足部感染者。
- 结果提示女性静脉壁对感染相关炎症存在性别特异性反应,支持对女性加强感染感知的移植物监测。
研究设计与样本
- 单中心回顾性研究,2000-2014年共318例肢体,女性74例(23%)。
- 排除30天内闭塞移植物后,232例纳入分析(男性182例,女性50例),仅限单静脉移植物。
- 采用倾向性评分卡钳内马氏距离1:1最优匹配及逆概率加权(主要推断),死亡作为竞争风险。
主要发现
- 匹配后(48对),女性5年静脉移植物狭窄累积发生率44% vs 男性9%(log-rank P=.004),一期通畅率52% vs 88%(P=.003)。
- 二期通畅率(85% vs 98%,P=.06)和保肢率(P=.60)无显著差异。
- 加权分析证实超额风险(校正HR 2.13;95%CI 1.13-4.02;P=.019)。
- 5年死亡率男性55% vs 女性35%;以死亡为竞争风险,女性狭窄发生率仍更高(34% vs 16%)。
- 术前高级别足部感染与女性狭窄相关(HR 4.27;95%CI 1.56-11.70;P=.005),男性无关联(HR 0.87;P=.74),性别-感染交互作用显著(P=.026)。
关键数值与推荐
- 狭窄经双功超声监测诊断,切除段行组织学检查。
- 全部25例切除狭窄段均显示内膜增生而无活动性炎症,病原体类型与狭窄无关。
- 女性中足部感染、静脉质量差和流出道阻力为独立相关因素。
临床怎么用
- 对女性慢性肢体威胁性缺血行单静脉远端旁路术后,应加强移植物监测,尤其术前存在足部感染者。
- 术前评估足部感染并控制感染相关炎症可能有助于降低女性静脉移植物狭窄风险。
局限性
- 单中心回顾性设计,样本量有限,女性仅50例纳入分析。
- 结论需外推至其他中心或人群时需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Sex differences in lower-extremity bypass outcomes remain controversial, and the mechanism is unclear. We examined whether female sex is associated with vein graft stenosis, predominantly due to intimal hyperplasia, after distal bypass for chronic limb-threatening ischemia, and whether preoperative foot infection contributes. METHODS: We studied 318 limbs with chronic limb-threatening ischemia undergoing para- or inframalleolar autogenous vein bypass at a single center (2000-2014; 74 women, 23%). All analyses were restricted to single-vein grafts; after excluding grafts occluding within 30 days, 232 formed the analytic cohort (182 men, 50 women). Female versus male outcomes were compared by 1:1 optimal matching (Mahalanobis distance within a propensity-score caliper on six covariates) and by inverse-probability-of-treatment weighting, which was the primary inference; death was treated as a competing risk. Stenosis was diagnosed by duplex surveillance, with histologic examination of excised segments. Wound, ischemia, and foot infection grades and preoperative C-reactive protein and fibrinogen were analyzed by sex with sex-by-exposure interaction terms; wound cultures were reviewed. RESULTS: After matching (48 pairs), the 5-year cumulative incidence of vein graft stenosis remained higher in women (44% vs 9%; log-rank P=.004), and primary patency was lower (52% vs 88%; P=.003); secondary patency (85% vs 98%; P=.06) and limb salvage (P=.60) did not differ significantly. Weighting confirmed the excess (adjusted hazard ratio 2.13; 95% confidence interval 1.13-4.02; P=.019). Five-year mortality was 55% in men vs 35% in women; with death as a competing risk, stenosis incidence remained higher in women (34% vs 16%). Preoperative high-grade foot infection was associated with stenosis in women (hazard ratio 4.27; 95% confidence interval 1.56-11.70; P=.005) but not men (hazard ratio 0.87; P=.74), with a significant sex-by-infection interaction (P=.026); wound and ischemia grades showed no sex difference. C-reactive protein and fibrinogen showed the same direction without a significant interaction. All 25 excised stenotic segments showed intimal hyperplasia without active inflammation, and organism type was unrelated to stenosis. In women, foot infection, poor vein quality, and run-off resistance were independent correlates. CONCLUSIONS: Women undergoing single-vein distal bypass for chronic limb-threatening ischemia have a higher incidence of vein graft stenosis despite balanced baseline risk, with the excess concentrated in those with preoperative foot infection. The findings suggest a sex-specific vein-wall response to infection-related inflammation and support intensified, infection-aware graft surveillance in women.
引用
- Okuda H, Kikuchi S, Koya A, et al. Sex-specific association between preoperative foot infection and vein graft stenosis after distal bypass for chronic limb-threatening ischemia. J Vasc Surg. 2026. PMID: 42855021. doi:10.1016/j.jvs.2026.10.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。